💊 The climate summit for implementation fails to implement much; A Kable look at the Brazil pharma story
#220 | AstraZeneca donates flu vaccines... not out of choice
Hello, and welcome back to The Kable. We hope you had a great weekend. We hope it was better than AstraZeneca's, whose price negotiations for flu vaccines dragged on with Swiss authorities for so long the company ended up donating 10,000 doses before they expired.
There was good news, too, for AstraZeneca as it set up a new manufacturing plant in Qassim, Saudi Arabia, in partnership with local drugmaker Saudi Pharmaceutical Industries & Medical Appliances Corporation (Spimaco).
Today's Kable is light, as Mondays often are. But we have some key takeaways from the recently concluded COP27 to mull over. And also the first of our series of market snapshots detailing the market scape in countries across Africa, Latin America and MENA. Today's snapshot takes you surfing across to Brazil, LatAm's biggest market for pharma.
Elsewhere, while the rest of the world looks to move away from Covid, China continues to lean into Zero Covid, now locking down an entire district in Guangzhou and schools across the country returning to online classrooms.